Analysis of candidate genes for macular telangiectasia type 2
暂无分享,去创建一个
Tunde Peto | Martin Friedlander | Mark C. Gillies | John Greenwood | Carmel Toomes | Marcus Fruttiger | Chris F. Inglehearn | Stephen E. Moss | Lois E. H. Smith | T. Peto | Carl Schubert | A. Bird | J. Greenwood | M. Gillies | R. Allikmets | C. Inglehearn | C. Toomes | M. Fruttiger | S. Moss | J. Merriam | M. Friedlander | Rando Allikmets | Alan C. Bird | Maria J. Figueroa | Nancy L. Parmalee | Carl Schubert | Joanna E. Merriam | Kaija Allikmets | Maria Figueroa | Lois E.H. Smith | N. Parmalee | K. Allikmets
[1] R. Bone,et al. Lutein, zeaxanthin, and the macular pigment. , 2001, Archives of biochemistry and biophysics.
[2] Hendrik P N Scholl,et al. Reading performance is reduced by parafoveal scotomas in patients with macular telangiectasia type 2. , 2009, Investigative ophthalmology & visual science.
[3] S. Madden,et al. Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor Angiogenesis , 2005, Clinical Cancer Research.
[4] M. Trese,et al. Clinical presentation and genetic correlation of patients with mutations affecting the FZD4 gene. , 2009, Archives of ophthalmology.
[5] J. Slakter,et al. RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.
[6] K Oshima,et al. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity , 2003, The British journal of ophthalmology.
[7] F. Bandello,et al. The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. , 2006, Annals of the Academy of Medicine, Singapore.
[8] A. Lotery,et al. Idiopathic juxtafoveolar retinal telangiectasis in monozygotic twins , 2007, British Journal of Ophthalmology.
[9] J. Nathans,et al. Vascular Development in the Retina and Inner Ear Control by Norrin and Frizzled-4, a High-Affinity Ligand-Receptor Pair , 2004, Cell.
[10] T. Berendschot,et al. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. , 2008, Investigative ophthalmology & visual science.
[11] I. Castan-Laurell,et al. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] W. Rizzo,et al. Sjögren‐Larsson syndrome: Diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2) , 2005, Human mutation.
[13] G. Virgili,et al. Bilateral juxtafoveolar telangiectasis in monozygotic twins. , 2000, American journal of ophthalmology.
[14] P. Charbel Issa,et al. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. , 2007, Investigative ophthalmology & visual science.
[15] C. Grimm,et al. Role of the Norrie disease pseudoglioma gene in sprouting angiogenesis during development of the retinal vasculature. , 2005, Investigative ophthalmology & visual science.
[16] Anna L. Ells,et al. Severe retinopathy of prematurity associated with FZD4 mutations , 2010, Ophthalmic genetics.
[17] Justin A. Green,et al. Lutein and zeaxanthin in eye and skin health. , 2009, Clinics in dermatology.
[18] M. Lavail,et al. Expression of Reverse Cholesterol Transport Proteins Atp- Binding Cassette A1 (abca1) and Scavenger Receptor Bi (sr-bi) in the Retina and Retinal Pigment Epithelium Nih Public Access Author Manuscript $watermark-text , 2022 .
[19] P. Campochiaro,et al. Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization , 2000, Journal of cellular physiology.
[20] Lois E. H. Smith,et al. Retinopathy of Prematurity: Current Concepts in Molecular Pathogenesis , 2009, Seminars in ophthalmology.
[21] V. Haase,et al. The VHL tumor suppressor and HIF: insights from genetic studies in mice , 2008, Cell Death and Differentiation.
[22] R. Guymer,et al. THE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2: The Melbourne Collaborative Cohort Study , 2010, Retina.
[23] C. Albigès-Rizo,et al. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction , 2010, The FEBS journal.
[24] J. Cruysberg,et al. Patients with Sjögren-Larsson syndrome lack macular pigment. , 2010, Ophthalmology.
[25] G. Robinson,et al. Combination therapy for the treatment of ocular neovascularization , 2007, Angiogenesis.
[26] J. Chen,et al. Genomic response of hypoxic Müller cells involves the very low density lipoprotein receptor as part of an angiogenic network. , 2009, Experimental eye research.
[27] M. Rajappa,et al. Ocular angiogenesis: mechanisms and recent advances in therapy. , 2010, Advances in clinical chemistry.
[28] E. Chew,et al. Macular telangiectasia: a simplified classification. , 2006 .
[29] Frank G. Holz,et al. Metamorphopsia in patients with macular telangiectasia type 2 , 2009, Documenta Ophthalmologica.
[30] A. Fielder,et al. A mutation in the Norrie disease gene (NDP) associated with X–linked familial exudative vitreoretinopathy , 1993, Nature genetics.
[31] J. Provis,et al. Differential expression of anti-angiogenic factors and guidance genes in the developing macula , 2009, Molecular vision.
[32] J. Shaw,et al. Retinal vascular caliber and macular telangiectasia type 2. , 2009, Ophthalmology.
[33] P. Campochiaro,et al. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood–retinal barrier , 2004, Gene Therapy.
[34] S. Mukai,et al. The Wnt Signaling Pathway in Familial Exudative Vitreoretinopathy and Norrie Disease , 2007, Seminars in ophthalmology.
[35] L. Yannuzzi,et al. Idiopathic Macular Telangiectasia , 2006, Retina.
[36] F. Cremers,et al. Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP , 2010, Human mutation.
[37] M. Trese,et al. Genetic variants of frizzled‐4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity , 2005, Clinical genetics.
[38] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[39] Kumar,et al. Unusual , 2020, Organic letters.
[40] Don H. Anderson,et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in retinal and eye research.
[41] B. Hopkins,et al. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina. , 2009, American journal of physiology. Heart and circulatory physiology.
[42] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[43] Hendrik P N Scholl,et al. Familial asymptomatic macular telangiectasia type 2. , 2009, Ophthalmology.
[44] M. Kraus,et al. Isolation and Biochemical Characterization of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling* , 1999, The Journal of Biological Chemistry.
[45] A. Reichenbach,et al. Angiogenesis-related factors derived from retinal glial (Müller) cells in hypoxia , 2004, Neuroreport.
[46] P. V. van Diest,et al. Active HIF-1 in the Normal Human Retina , 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[47] Tunde Peto,et al. Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2 , 2010, Ophthalmic epidemiology.
[48] D. Steel,et al. Comment on macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia. , 2009 .
[49] Kang Zhang,et al. Spectrum and frequency of FZD4 mutations in familial exudative vitreoretinopathy. , 2004, Investigative ophthalmology & visual science.
[50] T. Berendschot,et al. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. , 2009, Experimental eye research.
[51] J. Shields,et al. UNUSUAL RETINAL AND RENAL VASCULAR LESIONS IN THE KLIPPEL‐TRENAUNAY-WEBER SYNDROME , 1992, Retina.
[52] J. Sahel,et al. The sarcoglycan–sarcospan complex localization in mouse retina is independent from dystrophins , 2005, Neuroscience Research.
[53] B. Blodi,et al. Idiopathic juxtafoveolar retinal telangiectasis , 1993 .
[54] W. Ouwehand,et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. , 2007, Blood.
[55] S. Mukai,et al. Familial Exudative Vitreoretinopathy , 2021, A Quick Guide to Pediatric Retina.
[56] P. Massin,et al. Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia , 2009, Eye.
[57] P. Charbel Issa,et al. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging , 2008, Acta ophthalmologica.
[58] L. Leyns,et al. Non‐conventional Frizzled ligands and Wnt receptors , 2008, Development, growth & differentiation.
[59] G. Lang,et al. [Retinal angiomatous proliferation in age-related macular degeneration]. , 2006, Klinische Monatsblatter fur Augenheilkunde.
[60] Paul S. Bernstein,et al. Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. , 2008, Survey of ophthalmology.
[61] H. Freyberger,et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. , 1993, The Journal of clinical investigation.
[62] Kari E North,et al. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: A HuGE review , 2008, Genetics in Medicine.